Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma Egham, UK and Copenhagen, Denmark – 11 June, 2024 – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, today announced its rare disease business has signed a strateg
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering Strategic partnership provides a seamless one-stop-shop for biopharmaceutical development and manufacturing for large pharma, mid-size biotech’s and startup developers.The AGC Biologics & BioConnection collaboration offers new option for companies evaluating the potential impact of U.S. BIOSECURE Act. SEATTLE & OSS – May 22, 2024AGC Biologics, a
TOKYO, May 13, 2024--AGC Glass Asia’s Mirox MNGE, a low lead mirror, is awarded with Cradle to Cradle Certified® at the Bronze level based on version 3.1.